YTHDF1 and neoplasm: The experimental data revealed that elevated YTHDF1 increased the cyclin B1 mRNA in an m(6)A-dependent manner to facilitate the tumor progression and adverse prognosis of KRAS/TP53-mutant LUAD patients [51].